Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Amneal Pharmaceuticals

Amneal Pharmaceuticals
2002 FOUNDED
PUBLIC STATUS
5K-10K EMPLOYEES
AMRX STOCK SYMBOL
14 INVESTMENTS
$5.13 SHARE PRICE (As of Wednesday Closing)
Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products and Specialty products. Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. It generates a majority of its revenue from the Generic business segment.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Drug Discovery
Stock Exchange
NYS
Primary Office
  • 400 Crossing Boulevard
  • 3rd Floor
  • Bridgewater, NJ 08807
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Amneal Pharmaceuticals’s full profile, request a free trial.

Amneal Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.27 - $14.79 $1.6B $5.32 -$2.63 3.09M 299M

Amneal Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 3,920,448 7,163,563
Revenue 1,726,573 1,662,991 1,033,654 1,018,225
EBITDA 194,744 78,252 288,320 303,120
Net Income (338,557) (169,726) 167,648 207,378
Total Assets 3,703,943 4,352,736 1,341,889
Total Debt 2,773,065 2,691,130 1,484,432 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Amneal Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Amneal Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Amneal Pharmaceuticals Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taro Pharmaceutical Industries Failed Transaction (M&A) Haifa Bay, Israel 0000 0000 00000000000
00000000 Corporation Basel, Switzerland 000000 000000000000
0000000 00000 Private Equity-Backed Pine Brook, NJ 0000 00000 000000000 00000
00000 Failed Transaction (M&A) Hafnarfjordur, Iceland 000000000000
00000 000000 Corporation Malvern, PA 000 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

Amneal Pharmaceuticals Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 10-Dec-2019 000000000000000000 00000 Pharmaceuticals 000000 00000
000000 00000000000 07-May-2018 000000000000000000 00000 Distributors (Healthcare)
00000 000000000000 04-May-2018 0000000000 Pharmaceuticals 000000 00000
0000000 000000000 01-May-2015 000000000000000000 00.000 Pharmaceuticals 000000 00000
Epsilon Pharmaceuticals 01-Dec-2014 Buyout/LBO 0000 Drug Discovery 000000 00000
To view this company’s complete investment and acquisition history, request access »

Amneal Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 01-Jun-2013 0000000000 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Amneal Pharmaceuticals Subsidiaries (2)

Company Name Industry Location Founded
Gemini Laboratories Distributors (Healthcare) Bridgewater, NJ 2013
0000000 000000000 Pharmaceuticals The Rocks, Australia 0000
To view this company’s complete subsidiary history, request access »

Amneal Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Amneal Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Amneal Pharmaceuticals Executive Team (36)

Name Title Board
Seat
Contact
Info
Chirag Patel Chief Executive Officer & Founder
Janos Vaczi President, European Operations
Todd Branning Chief Financial Officer & Senior Vice President
Kanu Patel Co-Founder, Chairman and Managing Director
Shankar Hariharan Ph.D Chief Scientific Officer & Executive Vice President

15 Former Executives

You’re viewing 5 of 36 executives. Get the full list »

Amneal Pharmaceuticals Board Members (7)

Name Representing Role Since Contact
Info
00000 00000000 0000 Amneal Pharmaceuticals Board Member 000 0000
0000 00000 Amneal Pharmaceuticals Co-Founder, Chairman and Managing Director 000 0000
000000 00000 Self Board Member 000 0000

4 Former Board Members

You’re viewing 3 of 7 board members. Get the full list »